Mr. Oliver O'Connor:

I do not accept the language. I do not accept the idea of "at the expense of". What I see is legitimate public investment in research and development and a large amount of private investment. Companies are making huge investment over many years in their own capacities to manufacture, develop and deliver and roll out on a global basis medicines and vaccines. I see them asking investors, pension funds and many other private organisations to invest in their companies, to put their money at risk. I see them getting rewarded for that. Yes of course there are profits in that area. There are also many investments which produce nothing. The public sector, as a matter of public policy, would have to consider whether states, such as Ireland, would be prepared to invest hundreds of millions of euro in investment projects that could produce nothing. The risk tolerance of states and the public sector is quite low for those things. The risk tolerance in private investment is somewhat higher. Therefore it is a blend of the two. My only-----